What We're Reading: Page 102
Industry reads hand-picked by our editors
May 15, 2023
-
Bloomberg
FDA Fast Tracked Drugs Make Companies Billions on Unproven Claims
-
Reuters
Drugmaker Athenex voluntarily files for U.S. Chapter 11 proceedings
-
Financial Times
Cash-strapped Novavax urges governments to honour Covid jab deals
-
MIT Technology Review
Why tiny viruses could be our best bet against antimicrobial resistance
May 12, 2023
-
Reuters
Pfizer CEO calls US drug price plan ‘negotiation with a gun to your head’
-
CNBC
GOP law cut Big Pharma tax rates by 40%, Senate report says
-
Axios
Inside HHS’ plan to develop next-generation COVID treatments
-
The New York Times
Addiction Treatment Medicine Is Vastly Underprescribed, Especially by Race, Study Finds
May 11, 2023
-
NBC News
Toddlers saw peanut allergies ease after wearing ‘peanut patch’ in trial
-
The Wall Street Journal
Convicted Pharma Fraudster Shkreli’s Companies File for Bankruptcy
-
Financial Times
Glass Lewis backs Carl Icahn’s push to oust Illumina’s chief and chair
-
The Guardian
‘Too greedy’: mass walkout at global science journal over ‘unethical’ fees
May 10, 2023
May 09, 2023
May 08, 2023
-
Reuters
After weight loss, Alzheimer’s may be next frontier for drugs like Ozempic
-
Science
‘It’s still killing and it’s still changing.’ Ending COVID-19 states of emergency sparks debate
-
Healthcare Dive
CDC Director Walensky to step down in June
-
The New York Times
Liz Holmes Wants You to Forget About Elizabeth
Previous
